Paul has more than 25 years’ experience in the pharma and biotech industry. Prior to joining Enterprise Therapeutics, he was Director of Early Clinical Development and Project Leader for RespiVert,, successfully leading both pre-clinical and clinical programs. Paul’s respiratory expertise was developed at GSK where he was more latterly Therapy Area Director for the Clinical Pharmacology Science and Operations team, leading a group delivering early clinical programs across the respiratory portfolio. Experience in late phase clinical development was also gained at companies including Servier and AstraZeneca.